Literature DB >> 613233

Immunogenetic aspects of nasopharyngeal carcinoma. V. Confirmation of a Chinese-related HLA profile (A2, Singapore 2) associated with an increased risk in Chinese for nasopharyngeal carcinoma.

M J Simons, G B Wee, D Singh, S Dharmalingham, N K Yong, J C Chau, J H Ho, N E Day, G De-Thé.   

Abstract

Histocompatibility locus A typing of 43 Malaysian Chinese and 51 Hong Kong Chinese patients with nasopharyngeal carcinoma (NPC) confirmed the association between the occurrence of A2-Sin 2 and the increased risk for NPC that was previously demonstrated in Singapore Chinese. The results support the previous interpretation that the histocompatibility locus A genotype of importance in NPC predisposition is the A2-Sin 2 haplotype. The histocompatibility locus A-linked, genetically determined NPC risk is common to Asian Chinese from at least three geographic locations.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 613233

Source DB:  PubMed          Journal:  Natl Cancer Inst Monogr        ISSN: 0083-1921


  4 in total

1.  HLA association with nasopharyngeal carcinoma in southern Tunisia.

Authors:  Hafedh Makni; Jamel Daoud; Hanène Ben Salah; Nedia Mahfoudh; Olfa Haddar; Héla Karray; Tahya Boudawara; Abdelmonême Ghorbel; Abdelmajid Khabir; Mounir Frikha
Journal:  Mol Biol Rep       Date:  2009-08-28       Impact factor: 2.316

2.  Cytochrome P450 2E1 polymorphism and nasopharyngeal carcinoma development in Thailand: a correlative study.

Authors:  N Kongruttanachok; S Sukdikul; S Setavarin; V Kerekhjanarong; P Supiyaphun; N Voravud; Y Poovorawan; A Mutirangura
Journal:  BMC Cancer       Date:  2001-05-25       Impact factor: 4.430

Review 3.  HLA associations with nasopharyngeal carcinoma.

Authors:  Xin Li; Ross Fasano; Ena Wang; Kai-Tai Yao; Francesco M Marincola
Journal:  Curr Mol Med       Date:  2009-08       Impact factor: 2.222

4.  HLA and nasopharyngeal carcinoma in Malays.

Authors:  S H Chan; C T Chew; U Prasad; G B Wee; N Srinivasan; N Kunaratnam
Journal:  Br J Cancer       Date:  1985-03       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.